← Leaderboards
Jennifer A Doudna
Yale University
$26,483,799
Attributed
$29,272,640
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$48,308,418 · 22
By mechanism
U19$14,758,325 · 2
RM1$10,392,626 · 1
P01$9,270,287 · 4
R01$3,579,534 · 3
UG3$2,357,806 · 1
U01$1,962,500 · 1
Top collaborators
- Jillian Banfield5 shared
- Ross C Wilson4 shared
Most similar at Yale University
Same institution · by research overlap
- Shangqin Guo$5,210,122
- William C. Sessa$34,897,684
- Antonio Giraldez$24,949,135
- Scott A Strobel$10,998,720
- Miguel A Talavera$56,668
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsTechnologyGenome EditingBaseMolecularGeneticGuide RnaIn VivoBiochemicalEnzymesCrispr/Cas TechnologyProductionVirusComplexClustered Regularly Interspaced Short Palindromic RepeatsPathway InteractionsGenesStructureInsightProgramsPropertyViralMediating
Grant awards (69)
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats$4,367,220
U19 · FY2025 · NS · contact PI
Resource Core III: Biological Impacts Core$623,889
U19 · FY2025 · NS · contact PI
Core 2$421,615
U54 · FY2025 · AI · contact PI
Targeted Delivery of Cas9 to Lung Epithelial Cells using Enveloped Delivery Vehicles$283,500
R21 · FY2025 · HL · contact PI
Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats$163,164
U19 · FY2025 · NS · contact PI
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats$4,490,047
U19 · FY2024 · NS · contact PI
Resource Core III: Biological Impacts Core$430,469
U19 · FY2024 · NS · contact PI
Core 2$265,257
U54 · FY2024 · AI · contact PI
Targeted Delivery of Cas9 to Lung Epithelial Cells using Enveloped Delivery Vehicles$236,250
R21 · FY2024 · HL · contact PI
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats$4,683,536
U19 · FY2023 · NS · contact PI
Core 2$325,773
U54 · FY2023 · AI · contact PI
Cas9 RNP delivery to immune cells in vivo via molecular targeting$1,257,377
UH3 · FY2022 · AI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems$392,500
U01 · FY2022 · AI · contact PI
Core 2$345,000
U54 · FY2022 · AI · contact PI
Center for Genome Editing and Recording$2,074,678
RM1 · FY2021 · HG · contact PI
Cas9 RNP delivery to immune cells in vivo via molecular targeting$776,316
UG3 · FY2021 · AI
Identifying and inhibiting the SARS-CoV-2 packaging mechanism$519,750
R21 · FY2021 · AI · contact PI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems$392,500
U01 · FY2021 · AI · contact PI
Center for Genome Editing and Recording$2,074,678
RM1 · FY2020 · HG · contact PI
Cas9 RNP delivery to immune cells in vivo via molecular targeting$781,190
UG3 · FY2020 · AI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems$392,500
U01 · FY2020 · AI · contact PI
Center for Genome Editing and Recording$19,236
RM1 · FY2020 · HG · contact PI
Center for Genome Editing and Recording$2,074,678
RM1 · FY2019 · HG · contact PI
Cas9 RNP delivery to immune cells in vivo via molecular targeting$800,300
UG3 · FY2019 · AI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems$392,500
U01 · FY2019 · AI · contact PI
Center for Genome Editing and Recording$2,074,678
RM1 · FY2018 · HG · contact PI
Expanding CRISPR-Cas editing technology through exploration of novel Cas proteins and DNA repair systems$392,500
U01 · FY2018 · AI · contact PI
Structural Studies of Type III CRISPR-Cas Surveillance Complexes$210,288
P01 · FY2018 · GM · contact PI
Center for Genome Editing and Recording$2,074,678
RM1 · FY2017 · HG · contact PI
Structural Studies of Type III CRISPR-Cas Surveillance Complexes$210,213
P01 · FY2017 · GM · contact PI
Structural Studies of Type III CRISPR-Cas Surveillance Complexes$210,100
P01 · FY2016 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$107,920
P50 · FY2016 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$109,840
P50 · FY2015 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$390,789
P50 · FY2014 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$109,688
P50 · FY2014 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$390,139
P50 · FY2013 · GM · contact PI
Minstrel HTUV Gallery 700 Automated Crystal Growth and Imaging System$376,616
S10 · FY2013 · OD · contact PI
Structure and Function of RNAi-related Nucleases$274,555
R01 · FY2013 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$106,522
P50 · FY2013 · GM · contact PI
Structure and Function of RNAi-related Nucleases$285,119
R01 · FY2012 · GM · contact PI
HARC Center: HIV Accessory and Regulatory Complexes$109,135
P50 · FY2012 · GM · contact PI
HCV IRES Control of Human Translational Initiation$627,169
R56 · FY2011 · AI · contact PI
Structure and Function of RNAi-related Nucleases$285,671
R01 · FY2011 · GM · contact PI
Program in Virus Translational Control$1,243,082
P01 · FY2010 · GM · contact PI
STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES$544,769
P01 · FY2010 · GM · contact PI
Structure and Function of RNAi-related Nucleases$289,063
R01 · FY2010 · GM · contact PI
Program in Virus Translational Control$1,219,616
P01 · FY2009 · GM · contact PI
STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES$534,497
P01 · FY2009 · GM · contact PI
Structure and Function of Dicer Enzymes$115,125
R01 · FY2009 · GM · contact PI
STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES$519,180
P01 · FY2008 · GM · contact PI
Structure and Function of Dicer Enzymes$218,254
R01 · FY2008 · GM · contact PI
Program in Virus Translational Control$1,185,065
P01 · FY2007 · GM · contact PI
STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES$519,388
P01 · FY2007 · GM · contact PI
Structure and Function of Dicer Enzymes$219,048
R01 · FY2007 · GM · contact PI
Program in Virus Translational Control$1,684,048
P01 · FY2006 · GM · contact PI
STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES$420,720
P01 · FY2006 · GM · contact PI
Structure and Function of Dicer Enzymes$226,334
R01 · FY2006 · GM · contact PI
Structure and Mechanism of Internal Ribosome Entry Sites$250,090
R01 · FY2005 · GM
Structure and Function of Dicer Enzymes$232,474
R01 · FY2005 · GM
Structure and Mechanism of Internal Ribosome Entry Sites$263,651
R01 · FY2004 · GM
Structure and Mechanism of Internal Ribosome Entry Sites$263,988
R01 · FY2003 · GM
Structure and Mechanism of Internal Ribosome Entry Sites$276,773
R01 · FY2002 · GM
STRUCTURE AND FUNCTION OF GROUP I INTRON RIBOZYME$174,159
P01 · FY2002 · GM
Nucleic Acids Gordon Research Conference$5,000
R13 · FY2002 · GM
ASSEMBLY OF HIGHER ORDER STRUCTURE IN GROUP I RIBOZYMES$192,508
R01 · FY2001 · GM
STRUCTURE AND FUNCTION OF GROUP I INTRON RIBOZYME$174,159
P01 · FY2001 · GM
STRUCTURE AND FUNCTION OF GROUP I INTRON RIBOZYME$174,159
P01 · FY2001 · GM
STRUCTURE AND FUNCTION OF GROUP I INTRON RIBOZYME$246,844
P01 · FY2000 · GM
ASSEMBLY OF HIGHER ORDER STRUCTURE IN GROUP I RIBOZYMES$186,881
R01 · FY2000 · GM